Showing results (201-210 of 2,709) with videos related to

Sort By:
Pageof 271
Fundamental & Clinical Pharmacology|October 16, 1999
Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approachF Odoul, C Le Guellec, J P Lamagnère, et al.
Fundamental & Clinical Pharmacology|January 8, 2000
Cardiovascular responses to intrathecal dopamine receptor agonists in conscious DOCA-salt hypertensive ratsS Lahlou
Fundamental & Clinical Pharmacology|May 5, 1999
Mibefradil, a potent CYP3A inhibitor, does not alter pravastatin pharmacokineticsL Becquemont, C Funck-Brentano, P Jaillon
Fundamental & Clinical Pharmacology|May 5, 1999
Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effectJ L Montastruc, P Verwaerde, M Pelat, et al.
Fundamental & Clinical Pharmacology|May 5, 1999
Comparative effects of mibefradil and other calcium antagonists on resistance arteries of different end organsR van der Lee, M Pfaffendorf, P A van Zwieten
Fundamental & Clinical Pharmacology|January 1, 1994
Epithelium modulates the kinetics of the response to substance P and its intrinsic activity in the guinea-pig tracheaA Da Silva, C Bertrand, Y Landry
Fundamental & Clinical Pharmacology|January 1, 1993
The NMDA receptor complexB Scatton
Fundamental & Clinical Pharmacology|January 1, 1993
Dopaminergic modulation of visual sensitivity in manG Masson, D Mestre, O Blin
Fundamental & Clinical Pharmacology|January 1, 1994
Histamine and serotonin released from the rat perfused heart by compound 48/80 or by allergen challenge influence noradrenaline or acetylcholine exocytotic releaseH Fuder, P Ries, P Schwarz
Fundamental & Clinical Pharmacology|January 1, 1993
Pharmacokinetics and pharmacodynamics of zolpidem following repeated doses in hemodialyzed uraemic patientsJ P Fillastre, S Geffroy-Josse, I Etienne, et al.
Pageof 271